Answers are grounded in this paper and cite their sources.
This case report presents an innovative, minimally invasive treatment for a Grade II medial collateral ligament (MCL) tear, utilizing ultrasound-guided injections of low molecular weight peptides (LWPs) and hydrolyzed collagen with vitamin C supplementation. The approach adds to the surgical literature by demonstrating the feasibility of a minimally invasive, image-guided therapy aimed at enhancing ligament healing, an important consideration for individuals seeking faster recovery and return to physical activities. A 50-year-old male amateur athlete presented with acute medial knee pain following a soccer game, diagnosed as a Grade II MCL tear. Key concerns included pain management and rapid recovery to resume sports activities. The patient was treated with two rounds of ultrasound-guided injections directly into the MCL, containing a novel solution of LWPs, hydrolyzed collagen, and vitamin C. This treatment was complemented by a physiotherapy regimen. Clinical outcomes showed significant improvements in pain, knee functionality, and stability, allowing a return to sports within three months. The patient achieved significant improvement as assessed by patient-reported outcome measures (PROMs), including a reduction in Visual Analogue Scale (VAS) pain scores from 7 to 1 and an increase in the Lysholm Knee Scoring Scale from 25 to 85. The case highlights the potential benefits of using targeted, biologically active compounds in non-surgical treatment of ligament injuries. It underscores the importance of innovative treatments that can significantly reduce recovery time and improve functional outcomes for athletes, suggesting a promising area for further research and application in sports medicine and orthopedics.
No takes yet. Share an insight, caveat, or question.
Donati et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: